YD Bio Limited Ordinary Shares (YDES)

NASDAQ·Healthcare·Biotechnology

$6.15

+1.41%

Mkt Cap $427.82M

No analyst coverage available

We don't have analyst ratings or price target data for YD Bio Limited Ordinary Shares yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.